Boston-based Dana-Farber Cancer Institute reported a slight increase in its operating income for the final three months of 2022, notching $51.6 million in the period as revenues grew 14.6 percent over the same period in 2021.
Read the full post on Becker's Hospital Review - Healthcare News
